Memory Clinical and Research Center of Saint-Etienne (CMRR), Neurology Unit, University Hospital of Saint-Etienne, Saint-Etienne, France.
Memory Clinical and Research Center of Lyon (CMRR), Aging Institute I-Vie, University Hospital of Lyon, Villeurbanne, France.
Int J Geriatr Psychiatry. 2020 Sep;35(9):1043-1050. doi: 10.1002/gps.5327. Epub 2020 Jul 7.
This study was aimed at evaluating the association between cognitive functioning and the occurrence of behavioral and psychological symptoms of dementia (BPSD) in patients with Alzheimer's disease (AD).
METHODS/DESIGN: The population is derived from the PACO cohort, including 237 patients with prodromal or mild AD. A neuropsychological tests battery exploring verbal and visual memory, language, attention, and executive functions was performed at baseline. BPSD were assessed at 6-, 12-, and 18-month follow-up with neuropsychiatric inventory (NPI).
Lower baseline performance on Stroop test interference score was associated with higher subsequent overall NPI scores (P = .006), subscores of anxiety/depression (P = .03), and apathy inventory (P = .01). Conversely, other executive functions, verbal or visual memory, and language performances were not associated with a higher risk of BPSD.
Our results suggest that poorer inhibition performance would be associated with a higher risk of 18-month BPSD occurrence, including anxiety, depression, and apathy. A better knowledge of the predictive factors of the BPSDs would make it possible to better identify the patients at risk, to propose preventive strategies and an earlier adapted care. J Am Geriatr Soc 68:-, 2020.
本研究旨在评估认知功能与阿尔茨海默病(AD)患者发生行为和心理症状的痴呆(BPSD)之间的关系。
方法/设计:该人群来源于 PACO 队列,包括 237 例前驱期或轻度 AD 患者。在基线时进行了一项神经心理学测试,包括言语和视觉记忆、语言、注意力和执行功能。在 6、12 和 18 个月的随访中,使用神经精神病学问卷(NPI)评估 BPSD。
Stroop 测试干扰评分较低与随后的整体 NPI 评分较高(P=0.006)、焦虑/抑郁亚评分(P=0.03)和淡漠量表(P=0.01)相关。相反,其他执行功能、言语或视觉记忆以及语言表现与 BPSD 的高风险无关。
我们的结果表明,较差的抑制表现与 18 个月 BPSD 发生的风险增加相关,包括焦虑、抑郁和淡漠。更好地了解 BPSD 的预测因素将有助于更好地识别高危患者,提出预防策略和更早的适应性护理。
美国老年学会杂志 68:-,2020 年。